Preclinical model drawbacks dampen UK innovation, ABPI report says
The ABPI says that industry and academia must come together to bridge the gap between academic and commercially ready preclinical models.
The ABPI says that industry and academia must come together to bridge the gap between academic and commercially ready preclinical models.
Massive Bio and ConcertAI revealed the AI oncology trial systems at SCOPE 2026.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Biorce secures $52.5m in Series A to expand AI clinical trial tech
Revealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs
Patient-centric approaches thrive on wearables and remote access in trials
Pharma’s AI prospects get nudged into the future with EU’s AI act